Biosfer Teslab to Boston
Biosfer to Boston, one of the 20 finalists projects of the international startups acceleration program, The Big Booster More information here.
Biosfer Teslab in the newspaper la Vanguardia
News about Biosfer Teslab appeared in the reportage of the la Vanguardia newspaper, 25 of October, 2015, it’s title was “Un test més efectiu per al ‘colesterol dolent’” that means “A more efective test for the ‘bad cholesterol’” More information here.
Open call to join our operations team
Biosfer Teslab, an in vitro diagnostic company that develops novel NMR-based tests to improve cardiovascular risk assessment in patients at high cardio-metabolic risk, is looking for candidates to join our operations team. The company arises from the research carried out at the Metabolomics Platform and the Lipids and Atherosclerosis Research Unit from the Rovira i […]
Open call for an Industrial Doctorate
Biosfer Teslab, an in vitro diagnostic company that develops novel NMR-based tests to improve cardiovascular risk assessment in patients at high cardio-metabolic risk, is looking for Industrial Doctorate candidates. The company arises from the research carried out at the Metabolomics Platform and the Lipids and Atherosclerosis Research Unit from the Rovira i Virgili University and […]
Practical Applications of NMR in Industry Conference (PANIC) – Feb 2015 La Jolla, CA
Roger Mallol will give a talk in the 3rd Annual Practical Applications of NMR in Industry Conference (PANIC) that will take place in La Jolla, CA, February 9-12, 2015. PANIC was initiated to provide an interactive forum for discussion of the latest developments in the use of NMR for practical applications to real problems faced […]
Call for an Industrial Doctoral Student
Biosfer Teslab is seeking candidates for an industrial doctorate to develop NMR-based in vitro diagnostic tests for cardiovascular risk assessment.
Biosfer Teslab will attend the “Atherosclerosis and Cardio-Endocrine Biomarkers” course
Biosfer Teslab will attend the “Atherosclerosis and Cardio-Endocrine Biomarkers” course to be held on 25th – 27th of September in Bruges and Mons, Belgium. The course is supported by The Belgian Atherosclerosis Society / Lipid Club (BAS / BLC) and the Royal Belgian Society of Clinical Chemistry (RBSCC). Further information about the program here.
Biosfer Teslab will be in the exhibition ‘Ahir, avui, demà, Catalunya Emprèn. Idees que mouen Catalunya’
Biosfer Teslab will be represented as an entrepreneur company in the exhibition ‘Ahir, avui, demà, Catalunya Emprèn. Idees que mouen Catalunya’. This exhibition will be at the 4 Catalan capitals: In Tarragona from 07/21/14 until 08/31/14 In Barcelona from 10/06/14 until 09/11/14 In Girona from 11/17/14 until 13/12/14 In Lleida from 19/12/14 until 01/10/15 In this […]
Biosfer Teslab has been invited to attend the 4th Meeting on Advanced Lipidology
Biosfer Teslab CEO, Roger Mallol, will give a talk in the 4th Meeting on Advanced Lipidology to be held on 4th and 5th July in Prullans (La Cerdanya). Meeting on Advanced Lipidology Program
Miguel Ángel Pardo joins Biosfer Teslab
Miguel Ángel Pardo, Doctor in Chemistry by the Universidad Complutense de Madrid, has joined Biosfer Teslab.
